1/30
Looks like no tags are added yet.
Commercialisation
Taking a pharmaceutical idea/technology and developing it into a product that can be marketed and sold
NCE meaning
New Chemical Entities = new molecules that can be used as medicines
Non-NCE
Exisitng drugs that are improved or reformulated
Enabling technologies
Technologies that help medicines work better
NCE pathway
undegoes development pathway
discovery
preclinical testing
Phase 1-3
Regulatory Review
Approval
Commercial product
post-market surveillance
Cons of NCE
very expensive: 1-2 mil
very slow: more than 10 yrs
high risk: many products fail during development
505 (b) 1
New drug/NCE
ANDA
Generic drugs
OTC monograph
certain over-the-counter drugs
505 (b)2
modified exisiting drugs
an abbreviated approval pathway
applicant can rely partly on existing information/data that they did not generate themselves
Examples of 505 (b) 2
dosage form
strength dose
route of administration
API in a combination product
modify an exisitng drug + use existing data = potentially faster
Super generics
Existing drug + innovative formulation
faster
cheaper
improved
lower risk
improve PK
increase absorption
increase bioavailabity
faster action
lower dose
improve PD
change distribution
increase efficacy
decrease toxicity
Development stages
Research: make the molecule/technology
Prove: proof of concept
protect: IP
improve: prototype optimisation
test: preclinical + clinical
approve: regulatory approval
sell: marketing/commercialisation
6 funding types Give A Very Important Little Drug
Grant funding: by government/research bodies (ARC/NHMRC)
Angel investors
Venture Captial
Public equity/IPO
Licensing or sale of technologu
Debt finance
NHMRC
supports health and medical research
focus on health outcomes
Cons of Grant funding
depends on milestones
need strict reporting requirements
budget restrict
some schemes may require payback if commercialisation arrangement change
Angel investors
money invested into a private company by wealthy independent investors
provide money and sometimes experience/knowledge
What stage angel normally supports
from early stage
Venture capital (VC)
high-risk investment in businesses with a potential for rapid growth/high-returns
VC investors recieve shares/equity in exchange for investment
IPO
Initial public offering
lists on a stock exchange for the first time
where companies offer their shares
ASX = Australian Securities Exchange
Pros of IPO
can raise significant capital
access to public investors
Cons of IPO
intensive reporting
public scrutiny
must answer to shareholders
growth expectations
listing fees
Licensing
a company gives another party the right to use its technology
may recieve on return:
upfront payment
royalties
Why license technology?
original company may not have enough
money, skills, manufacturing capability, clinical trial resources
Major disadvantage of licensing
loss of control
Debt finance
borrow money from a bank/financial instituation
needs collateral
ability to repay the loan
higher risk due to higher interest rate
Accelerating Commercialisation
Can provide funding to assist eligible commercialisation costs.
R&D tax incentive
allows eligible companies to recieve a tax benefit/deduction for research activities